A centralized resource for cancer prevention agents and support services
Official title: CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT
Funded at Midwest Research Institute · NIH-11123991 · Data updated 2026-11-12
This study is creating a central place to store and manage cancer-fighting substances to help researchers find better ways to prevent cancer, making it easier for them to conduct their important work.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Midwest Research Institute NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $5,242,045 |
| NIH project number | 75N91023D00010-P00002-759102300001-1 |
| Project ID | NIH-11123991 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at high risk for developing cancer who may benefit from preventive interventions.
✕Less likely to help
Patients who are not at risk for cancer or those who have already been diagnosed with cancer may not receive benefit from this research.
What this research studies
This research focuses on maintaining a centralized repository of chemopreventive agents to support studies aimed at preventing or reducing cancer. The program will ensure the proper acquisition, tracking, storage, and quality control of these agents, facilitating their use in clinical interventions. By providing essential logistical support, the repository aims to enhance the efficiency and effectiveness of cancer prevention research.
Why it matters
Potential benefit: If successful, this research could lead to more effective strategies for preventing cancer through the use of targeted chemopreventive agents.
How similar studies have gone: Previous research has shown success in using centralized repositories for chemopreventive agents, indicating a promising approach for future studies.
Where this research is happening
-
Midwest Research Institute
Kansas City, United States Active
Researchers
- Principal investigator: White, Jon — Midwest Research Institute
- Study coordinator: White, Jon
Related research
Other NIH-funded projects on the same topics.
-
BRIDGE Center: A shared biomanufacturing hub to move biologics and cell therapies toward clinic
A new shared facility will help speed up the development and early clinical testing of vaccines, biologics, and cell-based therapies.
-
Developing a new treatment for tuberculosis called Telacebec.
This study is testing a new medication called Telacebec (Q203) to see if it can help people with tuberculosis by making treatment safer and more effective, which could lead to shorter recovery times and better health outcomes.
-
Creating a new type of DNA vaccine for better immune responses
This study is testing a new type of vaccine made from DNA that could help boost your immune system against different diseases, and it's designed to be safe and effective for people like you.
-
Developing a live biotherapeutic to improve vaginal health
This study is testing a new treatment made from good bacteria to help women with bacterial vaginosis and improve their vaginal health, which may also lower the risk of cervical issues.
-
Understanding and improving pain management.
This study is all about finding quicker and better ways to understand and manage pain, so that people dealing with different pain conditions can get more effective treatments and feel better.
-
Developing a method to protect inner ear cells from antibiotic damage
This study is testing a new drug called ORC-13661 to see if it can help protect your hearing and balance while you’re being treated with certain antibiotics that can sometimes cause hearing loss.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.